In vitro comparison of immunological properties of cultured human mesenchymal cells from various sources

Yu G Suzdaltseva1, V V Burunova, I V Vakhrushev

  • 1Russian State Medical University. medcellbox@mail.ru

Insights

Mesenchymal stem cells from bone marrow, umbilical cord, and skin fibroblasts show tolerance to immune cells. These mesenchymal cells do not harm or activate immune cells in vitro, indicating immune privilege.

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Cell Biology

Background:

  • Mesenchymal stem cells (MSCs) are investigated for their immunomodulatory properties.
  • Understanding the interaction between MSCs and immune cells is crucial for therapeutic applications.

Purpose of the Study:

  • To investigate the in vitro interaction between mesenchymal cells of various origins and peripheral blood mononuclear cells.
  • To determine the potential for cell-mediated cytotoxicity and immune activation.

Main Methods:

  • Co-culture of mesenchymal stem cells (bone marrow, umbilical cord, skin fibroblasts) with allogeneic peripheral blood mononuclear cells.
  • Assessment of cell lysis by natural killer cells and cytotoxic lymphocytes.
  • Evaluation of cytotoxic effects on peripheral blood mononuclear cells and lymphocyte proliferation (T cells, B cells, NK cells, CD14+ cells).

Main Results:

  • Mesenchymal cells, regardless of origin, were not lysed by allogeneic natural killer cells or cytotoxic lymphocytes.
  • Mesenchymal cells did not exhibit cytotoxic effects on peripheral blood mononuclear cells.
  • No proliferation of T lymphocytes, B lymphocytes, natural killer cells, or CD14+ lymphocytes was observed in mixed cultures.

Conclusions:

  • Mesenchymal cells of different origins demonstrate mutual tolerance with allogeneic immunocompetent cells in vitro.
  • Mesenchymal cells possess inherent immune-evasive properties, suggesting potential for immunomodulatory therapies.